Testing effectiveness (Phase 2)Study completedNCT02819856
What this trial is testing
SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
Who this might be right for
Ototoxicity
Sound Pharmaceuticals, Incorporated 40
Showing 3 of 3 results